Thrivent Financial for Lutherans’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $69.6M | Buy |
1,147,974
+975,107
| +564% | +$56.8M | 0.13% | 179 |
|
|
2025
Q4 | $9.23M | Buy |
172,867
+9,407
| +6% | +$453K | 0.02% | 694 |
|
|
2025
Q3 | $7.37M | Buy |
163,460
+11,904
| +8% | +$556K | 0.01% | 719 |
|
|
2025
Q2 | $7.02M | Sell |
151,556
-11,755
| -7% | -$577K | 0.02% | 692 |
|
|
2025
Q1 | $9.91M | Sell |
163,311
-3,168
| -2% | -$185K | 0.02% | 616 |
|
|
2024
Q4 | $9.45M | Buy |
166,479
+49,678
| +43% | +$2.78M | 0.02% | 677 |
|
|
2024
Q3 | $6.04M | Buy |
116,801
+5,407
| +5% | +$254K | 0.01% | 850 |
|
|
2024
Q2 | $4.63M | Sell |
111,394
-12,449
| -10% | -$557K | 0.01% | 930 |
|
|
2024
Q1 | $6.72M | Sell |
123,843
-88,420
| -42% | -$4.5M | 0.01% | 776 |
|
|
2023
Q4 | $10.9M | Sell |
212,263
-39,279
| -16% | -$2.06M | 0.02% | 615 |
|
|
2023
Q3 | $14.6M | Sell |
251,542
-60,360
| -19% | -$3.7M | 0.03% | 494 |
|
|
2023
Q2 | $19.9M | Sell |
311,902
-17,789
| -5% | -$1.19M | 0.05% | 433 |
|
|
2023
Q1 | $22.8M | Buy |
329,691
+1,592
| +0.5% | +$112K | 0.06% | 389 |
|
|
2022
Q4 | $23.6M | Buy |
328,099
+192,969
| +143% | +$14.6M | 0.06% | 372 |
|
|
2022
Q3 | $9.61M | Sell |
135,130
-648
| -0.5% | -$47K | 0.03% | 599 |
|
|
2022
Q2 | $10.5M | Sell |
135,778
-21,890
| -14% | -$1.67M | 0.03% | 594 |
|
|
2022
Q1 | $11.4M | Buy |
157,668
+3,760
| +2% | +$252K | 0.02% | 644 |
|
|
2021
Q4 | $9.77M | Buy |
153,908
+5,667
| +4% | +$332K | 0.02% | 679 |
|
|
2021
Q3 | $8.87M | Buy |
148,241
+7,928
| +6% | +$522K | 0.02% | 709 |
|
|
2021
Q2 | $9.38M | Sell |
140,313
-72
| -0.1% | -$4.7K | 0.02% | 702 |
|
|
2021
Q1 | $8.86M | Buy |
140,385
+6,731
| +5% | +$419K | 0.02% | 698 |
|
|
2020
Q4 | $8.29M | Buy |
133,654
+4,092
| +3% | +$252K | 0.02% | 700 |
|
|
2020
Q3 | $7.81M | Buy |
129,562
+11,675
| +10% | +$703K | 0.02% | 673 |
|
|
2020
Q2 | $6.88M | Sell |
117,887
-2,200
| -2% | -$132K | 0.02% | 636 |
|
|
2020
Q1 | $6.68M | Sell |
120,087
-3,345
| -3% | -$204K | 0.02% | 590 |
|
|
2019
Q4 | $7.92M | Buy |
123,432
+36,977
| +43% | +$2.12M | 0.02% | 627 |
|
|
2019
Q3 | $4.38M | Buy |
86,455
+6,087
| +8% | +$286K | 0.01% | 717 |
|
|
2019
Q2 | $3.65M | Sell |
80,368
-75,539
| -48% | -$3.52M | 0.01% | 762 |
|
|
2019
Q1 | $7.44M | Sell |
155,907
-11,951
| -7% | -$595K | 0.02% | 573 |
|
|
2018
Q4 | $8.84M | Buy |
167,858
+86,738
| +107% | +$4.66M | 0.03% | 489 |
|
|
2018
Q3 | $5.04M | Buy |
81,120
+1,358
| +2% | +$80.6K | 0.02% | 648 |
|
|
2018
Q2 | $4.41M | Sell |
79,762
-363
| -0.5% | -$19.6K | 0.01% | 676 |
|
|
2018
Q1 | $5.07M | Sell |
80,125
-1,143
| -1% | -$73.5K | 0.02% | 645 |
|
|
2017
Q4 | $4.98M | Buy |
81,268
+3,383
| +4% | +$212K | 0.02% | 642 |
|
|
2017
Q3 | $4.96M | Buy |
77,885
+11,912
| +18% | +$696K | 0.02% | 607 |
|
|
2017
Q2 | $3.68M | Sell |
65,973
-2,196,530
| -97% | -$120M | 0.02% | 668 |
|
|
2017
Q1 | $123M | Buy |
2,262,503
+1,988,160
| +725% | +$109M | 0.53% | 41 |
|
|
2016
Q4 | $16M | Buy |
274,343
+159,590
| +139% | +$8.72M | 0.07% | 272 |
|
|
2016
Q3 | $6.2M | Buy |
114,753
+1,660
| +1% | +$107K | 0.03% | 512 |
|
|
2016
Q2 | $8.33M | Buy |
113,093
+2,010
| +2% | +$142K | 0.04% | 429 |
|
|
2016
Q1 | $7.11M | Buy |
111,083
+57,205
| +106% | +$3.61M | 0.03% | 462 |
|
|
2015
Q4 | $3.71M | Buy |
53,878
+8,230
| +18% | +$544K | 0.02% | 684 |
|
|
2015
Q3 | $2.7M | Sell |
45,648
-4,065
| -8% | -$258K | 0.01% | 719 |
|
|
2015
Q2 | $3.32M | Buy |
49,713
+2,185
| +5% | +$144K | 0.02% | 566 |
|
|
2015
Q1 | $3.06M | Buy |
47,528
+1,700
| +4% | +$106K | 0.02% | 596 |
|
|
2014
Q4 | $2.72M | Buy |
45,828
+2,470
| +6% | +$139K | 0.02% | 619 |
|
|
2014
Q3 | $2.21M | Buy |
43,358
+4,360
| +11% | +$218K | 0.01% | 662 |
|
|
2014
Q2 | $1.89M | Sell |
38,998
-3,470
| -8% | -$171K | 0.01% | 718 |
|
|
2014
Q1 | $2.21M | Buy |
42,468
+25
| +0.1% | +$1.33K | 0.01% | 576 |
|
|
2013
Q4 | $2.26M | Buy |
42,443
+4,145
| +11% | +$211K | 0.01% | 573 |
|
|
2013
Q3 | $1.77M | Sell |
38,298
-96,505
| -72% | -$4.24M | 0.01% | 609 |
|
|
2013
Q2 | $6.03K | Buy |
+134,803
| New | +$5.85M | 0.04% | 397 |
|
Other funds holding BMY
VCM
VPM
Thrivent Financial for Lutherans's BMY Position: Q1 2026 in Review
Thrivent Financial for Lutherans increased its Bristol-Myers Squibb (BMY) stake by 564% in Q1 2026, buying an estimated $56.8M and bringing the position to 1,147,974 shares worth $69.6M. The position accounts for 0.13% of the portfolio, ranked #179.
Thrivent Financial for Lutherans first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $123M in Q1 2017. 2,518 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Thrivent Financial for Lutherans held 1,147,974 shares of Bristol-Myers Squibb worth $69.6M as of Q1 2026.
- Thrivent Financial for Lutherans bought 975,107 Bristol-Myers Squibb shares in Q1 2026, an estimated $56.8M.
- Bristol-Myers Squibb made up 0.13% of Thrivent Financial for Lutherans's portfolio in Q1 2026, its #179 holding.
- Thrivent Financial for Lutherans first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
- Thrivent Financial for Lutherans's Bristol-Myers Squibb position peaked at $123M in Q1 2017.
- 2,518 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Thrivent Financial for Lutherans's 13F filing for Q1 2026, filed 1 May 2026.